Empagliflozin's prevention of HF progression is linked to reduced proximal tubule sodium-hydrogen exchanger 3 (NHE3) activity, euvolemia restoration, and renal mass maintenance (54). The gene discussed is SLC9A3; the disease is hydrops fetalis.